141 related articles for article (PubMed ID: 6779412)
1. Immunological analysis of plasminogen activators from cultured human cancer cells.
Naito S; Sueishi K; Hattori F; Tanaka K
Virchows Arch A Pathol Anat Histol; 1980; 387(3):251-7. PubMed ID: 6779412
[TBL] [Abstract][Full Text] [Related]
2. Immunological characterization of plasminogen activator activities in human tissues and body fluids.
Rijken DC; Wijngaards G; Welbergen J
J Lab Clin Med; 1981 Apr; 97(4):477-86. PubMed ID: 6782183
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolysis-inhibitory activity of cultured human cancer cell lines.
Naito S; Kinjo M; Nanno S; Kohga S; Oka K; Tanaka K
Gan; 1981 Feb; 72(1):1-7. PubMed ID: 6456167
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activators in normal tissue and carcinomas of the human oesophagus and stomach.
Sier CF; Verspaget HW; Griffioen G; Ganesh S; Vloedgraven HJ; Lamers CB
Gut; 1993 Jan; 34(1):80-5. PubMed ID: 8432457
[TBL] [Abstract][Full Text] [Related]
5. Characterization of plasminogen activator from two human renal carcinoma cell lines.
Nelson NF; Cieplak W; Dacus SC; Prager MD
J Cell Physiol; 1986 Mar; 126(3):435-43. PubMed ID: 2419348
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolytic activity of in vitro cultivated human bladder cell lines.
Hisazumi H; Andersson L; Collins VP
Urol Res; 1977; 5(3):133-9. PubMed ID: 144345
[TBL] [Abstract][Full Text] [Related]
7. Immunological characterization of plasminogen activators in human mixed saliva.
Kjaeldgaard A; Kjaeldgaard M
Acta Physiol Scand; 1986 Mar; 126(3):443-7. PubMed ID: 3515850
[TBL] [Abstract][Full Text] [Related]
8. Human synovial fibroblasts produce urokinase-type plasminogen activator.
Medcalf RL; Hamilton JA
Arthritis Rheum; 1986 Nov; 29(11):1397-401. PubMed ID: 3096341
[TBL] [Abstract][Full Text] [Related]
9. Analysis of expressions of components in the plasminogen activator system in high- and low-metastatic human lung cancer cells.
He C; He P; Liu LP; Zhu YS
J Cancer Res Clin Oncol; 2001; 127(3):180-6. PubMed ID: 11260863
[TBL] [Abstract][Full Text] [Related]
10. Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.
Zimmerman M; Quigley JP; Ashe B; Dorn C; Goldfarb R; Troll W
Proc Natl Acad Sci U S A; 1978 Feb; 75(2):750-3. PubMed ID: 204931
[TBL] [Abstract][Full Text] [Related]
11. Urokinase-plasminogen activator, a marker for aggressive breast carcinomas. Preliminary report.
Duffy MJ; O'Grady P; Devaney D; O'Siorain L; Fennelly JJ; Lijnen HJ
Cancer; 1988 Aug; 62(3):531-3. PubMed ID: 3134120
[TBL] [Abstract][Full Text] [Related]
12. Human seminal fibrinolytic activity: specific determinations of tissue plasminogen activator and urokinase.
Van Dreden P; Gonzalès J; Poirot C
Andrologia; 1991; 23(1):29-33. PubMed ID: 1910268
[TBL] [Abstract][Full Text] [Related]
13. Immunological characterization of plasminogen activators in human parotid saliva.
Kjaeldgaard M; Kjaeldgaard A
Arch Oral Biol; 1987; 32(12):855-7. PubMed ID: 3140770
[TBL] [Abstract][Full Text] [Related]
14. Secretion of plasminogen activators by human colorectal and gastric tumor explants.
Harvey SR; Lawrence DD; Madeja JM; Abbey SJ; Markus G
Clin Exp Metastasis; 1988; 6(6):431-50. PubMed ID: 3409559
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of plasminogen activators in cancers and normal mucosae of human urinary bladder.
Hasui Y; Suzumiya J; Marutsuka K; Sumiyoshi A; Hashida S; Ishikawa E
Cancer Res; 1989 Feb; 49(4):1067-70. PubMed ID: 2492205
[TBL] [Abstract][Full Text] [Related]
16. [The study of plasminogen activator in renal cell carcinoma with special remarks on urokinase type plasminogen activator].
Hata M
Nihon Hinyokika Gakkai Zasshi; 1989 Nov; 80(11):1558-65. PubMed ID: 2512407
[TBL] [Abstract][Full Text] [Related]
17. Urokinase and the urokinase receptor: association with in vitro invasiveness of human bladder cancer cell lines.
Hudson MA; McReynolds LM
J Natl Cancer Inst; 1997 May; 89(10):709-17. PubMed ID: 9168186
[TBL] [Abstract][Full Text] [Related]
18. Urokinase plasminogen activator and prognosis in breast cancer.
Duffy MJ; Reilly D; O'Sullivan C; O'Higgins N; Fennelly JJ
Lancet; 1990 Jan; 335(8681):108. PubMed ID: 1967386
[No Abstract] [Full Text] [Related]
19. Immunological identification of plasminogen activators in normal and malignant tissues of the oral cavity in man.
Ljungnér H; Björlin G; Astedt B
Int J Oral Surg; 1984 Aug; 13(4):334-8. PubMed ID: 6434453
[TBL] [Abstract][Full Text] [Related]
20. Cancer cells release a covalent complex containing disulfide-linked domains from urinary plasminogen activator, neural cell adhesion molecule, and haptoglobin alpha and beta chains.
Harvey SR; Nayak SK; Markus G; Ouhammouch M; Hemperly JJ; Dillman RO; Doyle DJ
Arch Biochem Biophys; 1997 Sep; 345(2):289-98. PubMed ID: 9308901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
